X
17Aug

UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?

Dechert LLP | | Return|
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By: Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/

Related

Two New NLRB Decisions Allow Employers to Limit Use of Its Email System and Preserve Confidentiality of Workplace Investigations

Q: What is the current rule on whether an employee can use our company’s email system to distribute...

Read More >

Biometric Privacy Class Actions By The Numbers: Analyzing Illinois’ Hottest Class Action Trend

Seyfarth Synopsis: Over the last few years, Illinois companies have quickly become aware of the risk...

Read More >

Managing Project Risk Associated with the Coronavirus Outbreak Through Force Majeure Provisions

Globally, many developers and contractors are scrambling to identify available contractual relief as...

Read More >

Employment Law in the Health Care Industry: 2019 Year in Review

2019 brought continuing changes to employment law issues affecting the health care industry. The fol...

Read More >

Five Things for Employers to Consider in 2020

Various changes to employment law are coming into force over the next few months which should prompt...

Read More >

Massachusetts Employers Receive New Guidance Regarding Reimbursement for Qualifying Paid Leave Plans Under the State’s PFML Law

The Massachusetts Department of Family and Medical Leave (“DFML”) continues to provide ongoing sub...

Read More >